The plummeting demand for Merck & Co.’s HPV vaccine Gardasil in China has forced the New Jersey drugmaker to rework its ...

As drugmakers strive to fine tune the delivery of their medications for better convenience and patient adherence, Halozyme is putting a recent acquisition in the space to work, thanks to a new tie- | ...

As biotechs face increasingly tight development timelines, scale-up headaches and, more recently, unpredictable policy fluctuations, one way to stand out as a CDMO partner is picking a specialty an | ...

The FDA is seeking (PDF) new powers to hold companies accountable for misleading direct-to-consumer (DTC) ads, adding legislat | The FDA is seeking new powers to hold companies accountable for ...

Among the measures ImmunityBio has implemented are “expanded promotional review protocols,” executive training and external ...

The doctors at fictional Sacred Heart Hospital are in, and so is Insulet’s real-life wearable insulin management system ...

Neurocrine Biosciences, forever a possible M&A target in the biopharma industry, is making a major acquisition itself. | ...

A phase 3 trial of patients with moderate-to-severe TED has shown that subcutaneous injection of Tepezza by way of an on-body ...

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

Forget March going out like a lamb. On the M&A landscape, March went out like a lion.  | In a flurry of activity, biopharma ...

VML Health, a marketing and communications company, has identified the concept's emergence as a trend affecting how ...

For more than a year, the biopharma industry has had to swiftly react to various tariff threats from the Trump administration. | The president has rolled out a 100% tariff rate on patented ...